This inventor holds 5 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kite Pharma, Inc.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: John M Rossi: Innovator in T Cell Immunotherapy
Introduction
John M Rossi is a prominent inventor based in Santa Monica, CA (US). He has made significant contributions to the field of immunotherapy, particularly in the development of chimeric receptor T cell treatments. With a total of 5 patents, his work focuses on innovative methods to enhance cancer treatment.
Latest Patents
Rossi's latest patents include groundbreaking methodologies for treating malignancies. The first patent, titled "Chimeric receptor T cell treatment using characteristics of the tumor microenvironment," provides methods for administering an effective dose of genetically modified T cell immunotherapy. This patent emphasizes the importance of characterizing the pre-infusion tumor microenvironment to determine the optimal dosage for treatment. The second patent, "Treatment using chimeric receptor T cells incorporating optimized polyfunctional T cells," also focuses on T cell immunotherapy. It outlines methods for determining an effective dose of polyfunctional T cells prior to patient administration.
Career Highlights
John M Rossi is currently associated with Kite Pharma, Inc., a leading company in the field of cell therapy. His work at Kite Pharma has positioned him as a key player in advancing cancer treatment through innovative immunotherapy solutions.
Collaborations
Rossi has collaborated with notable colleagues, including Adrian I Bot and William Y Go. These partnerships have further enriched his research and development efforts in the field of immunotherapy.
Conclusion
John M Rossi's contributions to T cell immunotherapy represent a significant advancement in cancer treatment. His innovative patents and work at Kite Pharma highlight his commitment to improving patient outcomes through cutting-edge research.